What is BGM Group's earnings per share (EPS)?

BGM Group (BGM) reported diluted earnings per share of -$0.18 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

BGM Group Financials

BGM

FY2025 annual

Revenue $37.9M +51.1% YoY

Net Income -$19.9M -1282.1% YoY

EPS (Diluted) -$0.18 YoY not available

Free Cash Flow -$3.9M -1395.3% YoY

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Sep 30, 2025 Reported Jul 21, 2026 Currency USD FYE September

BGM Group (BGM) reported $37.9M in revenue for fiscal year 2025, up 51.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BGM FY2025 2026-08-15

A goodwill-heavy balance sheet now carries a cost base that the revenue stream cannot support.

The gross-margin improvement in FY2025 did not carry through to operating profit: operating margin was -33.2% as SG&A expanded to $18.2M. Operating cash flow was -$2.4M versus free cash flow of -$3.9M, confirming that the enlarged cost base was not funded by operations.

Total assets reached $433.8M, with goodwill of $350.8M, making acquisition-related asset value the dominant balance-sheet feature rather than operating scale alone. The current ratio fell to 1.2x, so short-term liquidity narrowed even though leverage remained modest.

The share count rose from 7.2M to 200.6M between FY2024 and FY2025, materially changing per-share economics before profitability was established. FY2025 net loss was $19.9M while operating cash flow was -$2.4M; that gap indicates earnings were affected by non-cash or balance-sheet adjustments, not just cash operating performance.

Financial Health Signals

Financial Health Score 28/100

Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of BGM Group's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway

Dilution

R&D Intensity

Revenue Progress

Burn Trend

Not available for BGM Group, and counted as zero in the overall score.

Balance Sheet

Piotroski F-Score Partial

2/8

BGM Group passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing

N/A

BGM Group reported a net loss of $19.9M while operations used $2.4M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$37.9M

YoY+51.1%

5Y CAGR-5.4%

BGM Group generated $37.9M in revenue in fiscal year 2025. This represents an increase of 51.1% from the prior year.

EBITDA

-$11.1M

YoY-1751.0%

BGM Group's EBITDA was -$11.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 1751.0% from the prior year.

Net Income

-$19.9M

YoY-1282.1%

BGM Group reported -$19.9M in net income in fiscal year 2025. This represents a decrease of 1282.1% from the prior year.

EPS (Diluted)

-$0.18

BGM Group earned -$0.18 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow

-$3.9M

YoY-1395.3%

BGM Group recorded an outflow of $3.9M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 1395.3% from the prior year.

Cash & Debt

$9.8M

YoY0.0%

5Y CAGR-3.7%

BGM Group held $9.8M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding

201M

BGM Group had 201M shares outstanding in fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin

16.6%

YoY+0.3pp

5Y CAGR+1.6pp

BGM Group's gross margin was 16.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.3 percentage points from the prior year.

Operating Margin

-33.2%

YoY-30.9pp

5Y CAGR-42.8pp

BGM Group's operating margin was -33.2% in fiscal year 2025, reflecting core business profitability. This is down 30.9 percentage points from the prior year.

Net Margin

-52.6%

YoY-46.8pp

5Y CAGR-62.7pp

BGM Group's net profit margin was -52.6% in fiscal year 2025, showing the share of revenue converted to profit. This is down 46.8 percentage points from the prior year.

Return on Equity

-5.1%

YoY-1.7pp

5Y CAGR-24.5pp

BGM Group's ROE was -5.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 1.7 percentage points from the prior year.

Capital Allocation

R&D Spending

$673K

YoY-50.6%

5Y CAGR+65.6%

BGM Group invested $673K in research and development in fiscal year 2025. This represents a decrease of 50.6% from the prior year.

Capital Expenditures

$1.6M

YoY+552.4%

5Y CAGR+28.4%

BGM Group invested $1.6M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 552.4% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

BGM Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

BGM quarterly income statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	$37.9M+51.1%	$25.1M-46.0%	$46.5M-28.3%	$64.9M+13.6%	$57.1M+14.1%	$50.0M+8.5%	$46.1M-8.5%	$50.4M
Cost of Revenue	$31.6M+50.6%	$21.0M-53.1%	$44.7M-23.7%	$58.6M+13.9%	$51.5M+21.1%	$42.5M+16.7%	$36.4M-13.8%	$42.2M
Gross Profit	$6.3M+53.4%	$4.1M+134.9%	$1.8M-71.9%	$6.2M+10.4%	$5.6M-25.2%	$7.5M-22.1%	$9.7M+19.0%	$8.1M
R&D Expenses	$673K-50.6%	$1.4M+139.5%	$568K-53.6%	$1.2M+15204.3%	$8K-85.2%	$54K+22.7%	$44K	N/A
SG&A Expenses	$18.2M+449.3%	$3.3M-12.6%	$3.8M-8.1%	$4.1M+26.9%	$3.3M+19.2%	$2.7M-22.1%	$3.5M+62.0%	$2.2M
Operating Income	-$12.6M-2131.7%	-$564K+78.4%	-$2.6M-224.2%	$2.1M-12.0%	$2.4M-50.4%	$4.8M-22.1%	$6.2M+3.5%	$6.0M
Interest Expense	N/A	N/A	$99K+299.0%	$25K-56.9%	$58K-76.3%	$243K+8.6%	$224K+3.5%	$216K
Income Tax	$278K+144.8%	-$620K-382.9%	$219K+12.8%	$194K-23.8%	$255K-70.5%	$865K-16.3%	$1.0M+9.5%	$943K
Net Income	-$19.9M-1282.1%	-$1.4M+81.5%	-$7.8M-822.6%	$1.1M-65.9%	$3.2M-37.7%	$5.1M-14.3%	$5.9M+13.6%	$5.2M
EPS (Diluted)	-$0.18	-$0.20	-$1.08-820.0%	$0.15	$0.09-47.1%	$0.17-5.6%	$0.18	N/A

Metric	Q4'25	Q2'25	Q4'24	Q2'24	Q4'23	Q4'22	Q4'21	Q4'20

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, Interest Expense, Income Tax, Net Income, EPS (Diluted).

BGM Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

BGM quarterly balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Total Assets	$433.8M+718.5%	$53.0M+3.4%	$51.3M-20.6%	$64.5M-14.4%	$75.4M+56.5%	$48.1M+36.5%	$35.3M	N/A
Current Assets	$51.5M+73.2%	$29.8M-13.7%	$34.5M+14.9%	$30.0M-25.6%	$40.4M+7.6%	$37.5M+50.3%	$25.0M	N/A
Cash & Equivalents	$9.8M0.0%	$9.8M+31.3%	$7.5M-47.8%	$14.3M+36.8%	$10.5M-11.8%	$11.9M+158.3%	$4.6M-18.3%	$5.6M
Inventory	$20.1M+298.1%	$5.0M+1.2%	$5.0M-43.8%	$8.9M-28.9%	$12.5M+4.2%	$12.0M-4.2%	$12.5M	N/A
Accounts Receivable	$4.3M+175.6%	$1.5M-21.9%	$2.0M+142.3%	$815K-53.0%	$1.7M+55.0%	$1.1M+85.3%	$604K	N/A
Goodwill	$350.8M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$41.9M+370.4%	$8.9M+29.0%	$6.9M-27.8%	$9.6M-48.8%	$18.7M-3.2%	$19.3M+52.8%	$12.6M	N/A
Current Liabilities	$41.6M+374.0%	$8.8M+31.8%	$6.7M-27.5%	$9.2M-49.5%	$18.2M-1.4%	$18.4M+58.0%	$11.7M	N/A
Total Equity	$390.9M+814.5%	$42.7M-0.1%	$42.8M-19.3%	$53.1M-3.3%	$54.9M+110.2%	$26.1M+31.2%	$19.9M+12.3%	$17.7M
Retained Earnings	-$15.8M-462.7%	$4.3M-26.2%	$5.9M-62.0%	$15.5M+5.5%	$14.7M+20.5%	$12.2M+61.3%	$7.6M	N/A

Metric	Q4'25	Q2'25	Q4'24	Q2'24	Q4'23	Q4'22	Q4'21	Q4'20
Total Assets	$433.8M+109.2%	$207.4M+291.3%	$53.0M+6.3%	$49.9M-2.7%	$51.3M-20.6%	$64.5M-14.4%	$75.4M+56.5%	$48.1M
Current Assets	$51.5M+20.0%	$42.9M+44.3%	$29.8M-10.7%	$33.3M-3.4%	$34.5M+14.9%	$30.0M-25.6%	$40.4M+7.6%	$37.5M
Cash & Equivalents	$9.8M+1.7%	$9.7M-1.7%	$9.8M-5.1%	$10.3M+38.4%	$7.5M-47.8%	$14.3M+36.8%	$10.5M-11.8%	$11.9M
Inventory	$20.1M+127.2%	$8.8M+75.2%	$5.0M+8.6%	$4.7M-6.8%	$5.0M-43.8%	$8.9M-28.9%	$12.5M+4.2%	$12.0M
Accounts Receivable	$4.3M-23.0%	$5.5M+257.9%	$1.5M+115.1%	$717K-63.7%	$2.0M+142.3%	$815K-53.0%	$1.7M+55.0%	$1.1M
Goodwill	$350.8M+159.4%	$135.2M	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$41.9M+75.4%	$23.9M+168.3%	$8.9M+80.7%	$4.9M-28.6%	$6.9M-27.8%	$9.6M-48.8%	$18.7M-3.2%	$19.3M
Current Liabilities	$41.6M+76.4%	$23.6M+168.8%	$8.8M+85.6%	$4.7M-29.0%	$6.7M-27.5%	$9.2M-49.5%	$18.2M-1.4%	$18.4M
Total Equity	$390.9M+114.6%	$182.1M+326.1%	$42.7M-1.6%	$43.4M+1.5%	$42.8M-19.3%	$53.1M-3.3%	$54.9M+110.2%	$26.1M
Retained Earnings	-$15.8M-552.3%	$3.5M-19.8%	$4.3M-30.5%	$6.3M+6.2%	$5.9M-62.0%	$15.5M+5.5%	$14.7M+20.5%	$12.2M

Not reported in any period shown, so not listed: Long-Term Debt.

BGM Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

BGM quarterly cash flow statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Operating Cash Flow	-$2.4M-535.9%	$544K+74.3%	$312K-97.5%	$12.7M+3567.5%	$345K-93.2%	$5.1M+974.9%	-$580K-113.1%	$4.4M
Capital Expenditures	$1.6M+552.4%	$240K+33.6%	$180K-91.2%	$2.0M+36.1%	$1.5M+232.3%	$450K-27.0%	$616K-44.8%	$1.1M
Free Cash Flow	-$3.9M-1395.3%	$304K+129.6%	$132K-98.8%	$10.6M+1023.9%	-$1.1M-124.8%	$4.6M+486.6%	-$1.2M-136.0%	$3.3M
Investing Cash Flow	-$163K-116.6%	$983K+120.7%	-$4.7M-45.5%	-$3.3M+86.5%	-$24.2M-6343.2%	-$376K+53.1%	-$800K+42.3%	-$1.4M
Financing Cash Flow	$2.6M+632.6%	-$492K+83.2%	-$2.9M+50.8%	-$5.9M-124.7%	$24.0M+1020.9%	$2.1M+322.0%	$507K+116.3%	-$3.1M
Dividends Paid	N/A	N/A	$1.8M	N/A	N/A	N/A	N/A	$734K

Metric	Q4'25	Q2'25	Q4'24	Q2'24	Q4'23	Q4'22	Q4'21	Q4'20

Not reported in any period shown, so not listed: Operating Cash Flow, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

BGM Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

BGM quarterly financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Gross Margin	16.6%+0.3pp	16.4%+12.6pp	3.8%-5.8pp	9.6%-0.3pp	9.9%-5.2pp	15.1%-5.9pp	21.0%+4.8pp	16.2%
Operating Margin	-33.2%-30.9pp	-2.3%+3.4pp	-5.6%-8.9pp	3.2%-0.9pp	4.2%-5.4pp	9.6%-3.8pp	13.4%+1.5pp	11.9%
Net Margin	-52.6%-46.8pp	-5.8%+11.0pp	-16.7%-18.4pp	1.7%-3.9pp	5.5%-4.6pp	10.1%-2.7pp	12.8%+2.5pp	10.3%
Return on Equity	-5.1%-1.7pp	-3.4%+14.8pp	-18.2%-20.2pp	2.0%-3.7pp	5.8%-13.7pp	19.4%-10.3pp	29.7%+0.3pp	29.4%
Return on Assets	-4.6%-1.9pp	-2.7%+12.5pp	-15.2%-16.8pp	1.7%-2.5pp	4.2%-6.3pp	10.5%-6.2pp	16.8%	N/A
Current Ratio	1.24-2.2x	3.39-1.8x	5.18+1.9x	3.27+1.1x	2.22+0.2x	2.04-0.1x	2.14	N/A
Debt-to-Equity	0.11-0.1x	0.210.0x	0.160.0x	0.18-0.2x	0.34-0.4x	0.74+0.1x	0.63	N/A
FCF Margin	-10.4%-11.6pp	1.2%+0.9pp	0.3%-16.1pp	16.4%+18.4pp	-2.0%-11.3pp	9.3%+11.8pp	-2.6%-9.2pp	6.6%

Metric	Q4'25	Q2'25	Q4'24	Q2'24	Q4'23	Q4'22	Q4'21	Q4'20
Current Ratio	1.24-0.6x	1.82-1.6x	3.39-3.7x	7.05+1.9x	5.18+1.9x	3.27+1.1x	2.22+0.2x	2.04
Debt-to-Equity	0.110.0x	0.13-0.1x	0.21+0.1x	0.110.0x	0.160.0x	0.18-0.2x	0.34-0.4x	0.74

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, FCF Margin.

Similar Companies

Harrow Health Inc HROW

$1.4B

Phibro Animal PAHC

$1.5B

Avadel Pharmaceu AVDL

$2.1B

Amphastar Pharma AMPH

$930.7M

Biocryst Pharmaceuticals Inc BCRX

$2.5B

Where BGM Group Ranks

Frequently Asked Questions

What is BGM Group's annual revenue?

BGM Group (BGM) reported $37.9M in total revenue for fiscal year 2025. This represents a 51.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is BGM Group's revenue growing?

BGM Group (BGM) revenue grew by 51.1% year-over-year, from $25.1M to $37.9M in fiscal year 2025.

Is BGM Group profitable?

No, BGM Group (BGM) reported a net income of -$19.9M in fiscal year 2025, with a net profit margin of -52.6%.

What is BGM Group's EBITDA?

BGM Group (BGM) had EBITDA of -$11.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is BGM Group's gross margin?

BGM Group (BGM) had a gross margin of 16.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is BGM Group's operating margin?

BGM Group (BGM) had an operating margin of -33.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is BGM Group's net profit margin?

BGM Group (BGM) had a net profit margin of -52.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is BGM Group's return on equity (ROE)?

BGM Group (BGM) has a return on equity of -5.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is BGM Group's free cash flow?

BGM Group (BGM) recorded an outflow of $3.9M in free cash flow during fiscal year 2025. This represents a -1395.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is BGM Group's operating cash flow?

BGM Group (BGM) recorded an outflow of $2.4M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are BGM Group's total assets?

BGM Group (BGM) had $433.8M in total assets as of fiscal year 2025, including both current and long-term assets.

What are BGM Group's capital expenditures?

BGM Group (BGM) invested $1.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does BGM Group spend on research and development?

BGM Group (BGM) invested $673K in research and development during fiscal year 2025.

How many shares does BGM Group have outstanding?

BGM Group (BGM) had 201M shares outstanding as of fiscal year 2025.

What is BGM Group's current ratio?

BGM Group (BGM) had a current ratio of 1.24 as of fiscal year 2025, which is considered adequate.

What is BGM Group's debt-to-equity ratio?

BGM Group (BGM) had a debt-to-equity ratio of 0.11 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is BGM Group's return on assets (ROA)?

BGM Group (BGM) had a return on assets of -4.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

How does BGM Group's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, BGM Group (BGM) held $21.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $2.4M over that year. Dividing the one by the other, the reported balance equals about 108 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is BGM Group's Piotroski F-Score?

BGM Group (BGM) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are BGM Group's earnings high quality?

BGM Group (BGM) reported a net loss of $19.9M while operations used $2.4M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is BGM Group?

BGM Group (BGM) scores 28 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.